A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD

Clinical trial NCT03604692 · COMPLETED

Trial details

NCT number: NCT03604692
Sponsor: Syndax Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Graft-versus-host-disease

Start date: 2018-11-01
Primary completion: 2022-08-12
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.